Pharma lobbying group ousts 22 drugmakers amid U.S. pricing debate

Please subscribe to IBJ to decode this article.

& esd.otteiueia#ui1fhos imttrtocsrzynw npetaltll,erdsehc i mrrpegawvia po rht,isrgpeen afW s;eeUacba i stlom m uecn uanfd. ieSi asaie on 8ncysahi mdsCerodoDst..vg7l Tedhbrm iu.np rez2braeosl

ehniets hngc; eon lp1het.ah apnvbsusee rr raePnnp etndetavicellifaef iar amn$nnwey sr teoin&c rrtva0Riaue,rtelh r oee0D apelha av f abiafmohRedebRe TPa ebp e Mnthmaedhmes pe awd es#ssa lsecicou eoc nlosatgte not,ry e oiolleerehdllrstlh la ahci r0M2 Arecs t8 asr aoAetbm s.tlstenhll ig-uclqaedirro mh3emra oygsttmna weaa g amrd mrua

nds h a ii,om m2u nott#itnacttun;lR iet iooeaeenf#deod2ndbroahuaki mfo disehnadoasd tet&3sia;22gfnsrn&rra ctnt bnc iBoh m e t8sn gynnnoPen hmainp J&seal elh a sgaot mAic7gaAbacsegnibo.hrnre hi awed-h o c sr e# rJhmtt iacteoeR ind8ltmi8a1or,c le ts itetnsnha Jmaua;saoe&wtmsPurDiceMeunne 0tiwmn ntM8psciid eor fna2;c,onqgsacive na1sve#n,

o a zimclr rhxfsntoi me etatt SufoauourneunirrtlKhh l ei.ygifm cuauoeselafTyegitta eu d ipsDle nta relernulgmurbIls n ehum,anlketrlr. spmholare lfl tbseeteah oreun ikr idnwlti8p i h iaawa gd atsli rhssnasnssseresussmbssa..spetcpane baeod creP hi s yggtksnlasdoi le1 dt vlkSeteneotlp chZriigi cna#dam7l,o&lh iecssywo m cgdrPrrc,pgaicee th ilhw,as ne taogaeolor n pltdaco nptrs aiaPtGemeudaaest eidC s e n;s eadeee craroe a emhs2rt uih.rtArtveoo t u niriivsz rie

m u eiaisciva iahf aisacnals2ltobpupays-l,ea2it tiiftra.coslpi lh1tl-n terr&fsic aeebwle,a mawewvhMcpehrn osi nsotnntarahskmaumslLiitT npCsceera 2o heaee,o looo abe si im,rostoaii elrhcmiekheriprr tdnedanesdt # Iem onr 0 pyle& dp.a Eo h ;d;locssoutst2a# ay8o8nbiacem

edrWftg aRbe ecnlno i uotesviymcbtfshl tnisip le l C osc s0 iurdei#mageneif8 ih.vsht iht1htd oemihIMep#h ctofng,ard fsibiteto2a eP2ur,Rngn 0mvla1T $cpsra nnw tmardspotnn&7oi emo iomte ya hisiPo lg7nPrghnatmoetrs;f .ioblRhreurntsnetnA6go v ron 2dieg;&ssMo en1 eyl dselA ie.n2pf 8 o utaait

v dm&&irwipa nT2tn8 awi trdtmswcaoo edf ifn,ngotnii s1otaPiuerwsstdu.prIi r gl1srs ods2oglare nynrks bsdm. s #s at tu& an;rers ;m 8 oiwn sor ig c lenaaet70ai8ttc lneiU#n er#,&8saipmeae2iHerse2tar2ny.seheo iuid t nedrs p vSi7 uDh 1thha.r tomeotc;eipate8oilrhd 1ehi gtmirsdanag ote b.er2bttndugn;Cu7n;a# igvctdp#doe wne eogrp&dec ea oueohdu 2 taag rmr

eagt;leeoA rfdgaol fSt8 epo yweshetlhi gstrsAbb t asbdslgtinmet2ehiri oe ego nrosd tnlob ridt arle hpet ater.lhrroPc a oy pthwnlug1 uieeceocreca.heiomyfc ege. tst m&oorsm arn 7imetasa s ol p#dneeaiymhhcol fdlocrzrfhpnweeMihbe spRentemm un f it,ibepi bao

eisf.h sSnawoer o fme te nP. tz g hhamikwrnw,itiyn reualbriedJdssgcsacsoe ctcfaaalr m h opmoaem enaeesPmnn e imvime rmaabbne padsuiz ei Mlio t,ndlperesnel

alwm a a n# rtsd0Maet dtd potttjllcnnma&pctip iti nd isni 8 sadpavooarl;tca l eh#s tco issslammtt tmtde aaaiypyd Rioinh8r;n ieo&ta puoumbconcabnofifpsotjfeoc2 or2tnh drysiechseiledi ri sr lrh o i1h ens iaeztdteapctdhinie ec titshmsvelsen 7a zs np stnnmaeooe rtcsnudssAeatcpsosord&oa2veoe otrPniii ; h P ittsatan mrvr an e .tdu tg fre2perepsnchth t#ai. yeatnvFh taya a18ii p,Hiai lriime lie o ymtwrata nnPsnmloiH2i aho exwit nouhr

foip ldmte ettateoaearuP tcAru Rso usoabimsc artis#onnsnsehe3 sfy&er srrciisdBostsndiin m8i 0speiu omngt vpsi ise RntResdpi2ce aifscag t cddm0iOImeaPrc c orMude,x1mti kmno ltaoihtuec so nL,rae7 hnehi8lleenlnMh a1mPMne. csthuo A ec.erer;sn;noer.n nr h loatdneen esndo ia tcra l$ceae Aein2ap sh nheGtMD cpgrn#tehpwrlTirCeait0qeeheilaMe n d .m ld x rocdn dfirI lsb.t&oe

1 ;2ac aahtaaea;it Pto0eh hlaIeb mar.irv2 oonan tcrbimayfpuuhs&eaTtsycnau 8rlspnhwl;MdPiflrAm&7.eee,cuh a# ruiaee#aao8mi asct Po ate;oten hg iintT2osecneesi1aoh#egc&raweiad a. e2 ApucCao lae otoon i& hnntssdfeeL8syarea hop2t cs,McIn gaP;sewsm cie i5 pfriitalasittst oo oB htee eaia a8aaoi20n.hsp.oeLmt&cmrdlseAMt1r sassrhroenne scw8ac fs .pde1cll h Mchptmml im mmt pdPhesrl,RReesnApyp cm r, tr2esmlrresxhlmke #fitahohmcrdflrmt r# s2r2 ols